Consulting & Data Analytics for the Nordic life sciences sector
Summary
Signum Life Science is a consulting and data analytics company supporting pharmaceutical, biotech, and broader life science sector clients across the Nordic region. Signum integrates data-driven insights, advanced analytics, and local Nordic expertise to help organisations succeed with product launches, real-world evidence (RWE), market access, and HCP engagement strategies.
Strategic and executional consulting across market access, RWE, launch planning and Nordic market insights.
Real-World Evidence (RWE) study design & execution
Nordic market insights & payer landscape
Market access strategy & HTA support
Launch planning & stakeholder mapping
Data & Analytics
Subscription data products, patient analytics and HCP engagement insights tailored for Nordic markets.
Sales performance data (Rx & OTC)
Patient journey & adherence analytics
HCP engagement optimisation
Dashboards & visualisation
Workshops & Insights
Hands-on workshops, thought-leadership reports and capacity-building sessions.
RWE workshops & training
Whitepapers & trend reports
Local market advisory
Target audience
Pharmaceutical companies, biotechnology firms and other companies within the life sciences sector (including medtech and healthcare data organisations) operating in or entering the Nordic markets.
Therapeutic areas & case studies
Therapeutic expertise
Oncology
Cardiovascular disease
Neurology
Immunology
Diabetes
Rare diseases
Case studies
Oncology — RWE enabling payer dialogue
Designed an RWE study that supported successful market access conversations with payers.